Nanxishan Hospital of Guangxi Zhuang Autonomous Region   Report issue

Academic/Hospital Phase 2
Founded: Guilin China (1968)

Organization Overview

First Clinical Trial
2020
NCT04157478
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Nanxishan Hospital | Nanxishan Hospital of Guangxi Zhuang Autonomous Region

Active Ingredients

Drugs in Phase 2 Trials (2)

anlotinib (1 trial)

temozolomide (temodar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2